Clinical Focus ›› 2012, Vol. 27 ›› Issue (14): 1218-0.
Previous Articles Next Articles
Expression of Zonula occlndens-1 protein in intestine in patients with nonalcoholic fatty liver disease
DAI Xin;LV Zong-shun;WANG Bang-mao;YANG Xue-min
-
Online:2012-07-20Published:2012-07-20
CLC Number:
Cite this article
DAI Xin;LV Zong-shun;WANG Bang-mao;YANG Xue-min. Expression of Zonula occlndens-1 protein in intestine in patients with nonalcoholic fatty liver disease[J]. Clinical Focus, 2012, 27(14): 1218-0.
share this article
Add to citation manager EndNote|Ris|BibTeX
| [1] | Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun. Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis [J]. Clinical Focus, 2025, 40(4): 293-303. |
| [2] | Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin. Value of T2WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients [J]. Clinical Focus, 2025, 40(3): 251-256. |
| [3] | Tong Mingxia, Chen Ke, Xiang Xiaocong, Zhou Lifeng. Analysis of lean metabolic-associated fatty liver disease among young and middle-aged people and its risk factors [J]. Clinical Focus, 2025, 40(2): 128-132. |
| [4] | Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146. |
| [5] | Sun Ya, Yang Shuang. Value of ultrasound-guided attenuation parameter in the quantitative assessment of hepatic steatosis [J]. Clinical Focus, 2025, 40(2): 158-161. |
| [6] | Gou Caixia, Zhang Jie, Baoyixiamu·Ababaikeli , Wang Yiming, Yao Lei, Zheng Rongjiong, Pan Jinliang, Lu Xiaobo. Analysis of influencing factors of sleep quality and metabolically associated fatty liver disease in the physical examination population [J]. Clinical Focus, 2025, 40(1): 33-38. |
| [7] | Zhang Shasha, Zhao Yingchun, Zhou Hongxia. Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir [J]. Clinical Focus, 2024, 39(11): 980-983. |
| [8] | . [J]. Clinical Focus, 2024, 39(10): 935-939. |
| [9] | Qin Qiaoling, Mo Ranghui, Chen Xinyi. Efficacy and safety of the direct-acting anti-HCV therapy based on efavirenz-containing regimen on HIV/HCV co-infected patients [J]. Clinical Focus, 2024, 39(10): 921-924. |
| [10] | Wu Qiupin, Yan Shiwei, He Xiaoyin, Li Yun, LU Liju, Wu Yi. Analysis of hepatitis associated aplastic anemia in children [J]. Clinical Focus, 2024, 39(7): 640-643. |
| [11] | . [J]. Clinical Focus, 2024, 39(7): 658-663. |
| [12] | . [J]. Clinical Focus, 2024, 39(2): 177-182. |
| [13] | . [J]. Clinical Focus, 2024, 39(1): 84-87. |
| [14] | . [J]. Clinical Focus, 2023, 38(10): 935-939. |
| [15] | . [J]. Clinical Focus, 2023, 38(6): 559-563. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||